Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions

Journal of Nuclear Medicine

Volumn 55, Issue 2, 2014, Pages 191-197

  Eiber, Matthias ^a   Takei, Toshiki ^a   Souvatzoglou, Michael ^a   Mayerhoefer, Marius E ^b   Fürst, Sebastian ^a   Gaertner, Florian C ^a   Loeffelbein, Denys J ^a   Rummeny, Ernst J ^a   Ziegler, Sibylle I ^a   Schwaiger, Markus ^a   Beer, Ambros J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bone lesion; Detection; Hybrid imaging; PET CT; PET MR; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; AGED; ANATOMICAL VARIATION; ARTICLE; BONE CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CHILD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; VERY ELDERLY; VOLUMETRY; BONE LESION; BONE TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DETECTION; HYBRID IMAGING; IMAGE PROCESSING; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIMODAL IMAGING; PATHOLOGY; PET/CT; PET/MR; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCINTISCANNING; SUV; WHOLE BODY IMAGING;

BONE LESION; DETECTION; HYBRID IMAGING; PET/CT; PET/MR; SUV;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 84897941968     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.123646     Document Type: Article

References (26)

1. Eiber M, Souvatzoglou M, Pickhard A, et al. Simulation of a MR-PET protocol for staging of head-And-neck cancer including Dixon MR for attenuation correction. Eur J Radiol. 2012;81: 2658-2665.
2. Drzezga A, Souvatzoglou M, Eiber M, et al. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53: 845-855.
3. Martinez-Möller A, Eiber M, Nekolla SG, et al. Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology. J Nucl Med. 2012;53: 1415-1426.
4. Antoch G, Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging. 2009;36(suppl 1): S113-S120.
5. Rubens RD. Bone metastases: the clinical problem. Eur J Cancer. 1998;34: 210-213.
6. Vanel D, Dromain C, Tardivon A. MRI of bone marrow disorders. Eur Radiol. 2000;10: 224-229.
7. Imamura F, Kuriyama K, Seto T, et al. Detection of bone marrow metastases of small cell lung cancer with magnetic resonance imaging: early diagnosis before destruction of osseous structure and implications for staging. Lung Cancer. 2000;27: 189-197.
8. Vanel D, Bittoun J, Tardivon A. MRI of bone metastases. Eur Radiol. 1998;8: 1345-1351.
9. Vanel D, Casadei R, Alberghini M, Razgallah M, Busacca M, Albisinni U. MR imaging of bone metastases and choice of sequence: spin echo, in-phase gradient echo, diffusion, and contrast medium. Semin Musculoskelet Radiol. 2009;13: 97-103.
10. Hofmann M, Pichler B, Schölkopf B, Beyer T. Towards quantitative PET/MRI: a review of MR-βased attenuation correction techniques. Eur J Nucl Med Mol Imaging. 2009;36(suppl 1): S93-S104.
11. Hofmann M, Bezrukov I, Mantlik F, et al. MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation-And atlas-based methods. J Nucl Med. 2011;52: 1392-1399.
12. Schulz V, Torres-Espallardo I, Renisch S, et al. Automatic, three-segment, MRbased attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging. 2011;38: 138-152.
13. Martinez-Möller A, Souvatzoglou M, Delso G, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009;50: 520-526.
14. Gaertner FC, Furst S, Schwaiger M. PET/MR: a paradigm shift. Cancer Imaging. 2013;13: 36-52.
15. Delso G, Fürst S, Jakoby B, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52: 1914-1922.
16. Maki JH, Chenevert TL, Prince MR. The effects of incomplete breath-holding on 3D MR image quality. J Magn Reson Imaging. 1997;7: 1132-1139.
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476): 307-310.
18. Kumar J, Seith A, Kumar A, et al. Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT. Pediatr Radiol. 2008;38: 953-962.
19. Schmidt GP, Schoenberg SO, Schmid R, et al. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol. 2007;17: 939-949.
20. Eiber M, Martinez-Möller A, Souvatzoglou M, et al. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions. Eur J Nucl Med Mol Imaging. 2011;38: 1691-1701.
21. Samarin A, Burger C, Wollenweber S, et al. PET/MR imaging of bone lesions: implications for PET quantification from imperfect attenuation correction. Eur J Nucl Med Mol Imaging. 2012;39: 1154-1160.
22. Souvatzoglou M, Ziegler SI, Martinez MJ, et al. Standardised uptake values from PET/CT images: comparison with conventional attenuation-corrected PET. Eur J Nucl Med Mol Imaging. 2007;34: 405-412.
23. Nakamoto Y, Osman M, Cohade C, et al. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl Med. 2002;43: 1137-1143.
24. 18F-FDG PET. J Nucl Med. 2005;46: 1819-1824.
25. Schirrmeister H. Detection of bone metastases in breast cancer by positron emission tomography. Radiol Clin North Am. 2007;45: 669-676.
26. 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16: 3375-3379.